Accepted for Publication: March 18, 2015.
Published Online: May 4, 2015. doi:10.1001/jamainternmed.2015.1513.
Study concept and design: Wilensky, Hirshfeld, Kumbhani, Giri.
Acquisition, analysis, or interpretation of data: Chatterjee, Herrmann, McCormick, Frankel, Yeh, Armstrong, Kumbhani, Giri.
Drafting of the manuscript: Chatterjee, Herrmann, Giri.
Critical revision of the manuscript for important intellectual content: Herrmann, Wilensky, Hirshfeld, McCormick, Frankel, Yeh, Armstrong, Kumbhani, Giri.
Statistical analysis: Chatterjee, Giri.
Administrative, technical, or material support: Chatterjee, Herrmann, Armstrong, Giri.
Study supervision: Wilensky, McCormick, Frankel, Armstrong, Kumbhani, Giri.
Conflict of Interest Disclosures: Dr Yeh is on the advisory board for Abbott Vascular; is a consultant for Gilead Sciences; and receives research support and salary from Harvard Clinical Research Institute. Dr Armstrong is on the advisory board for Abbott Vascular and is a consultant for Angioscore. Dr Kumbhani is a consultant for the American College of Cardiology. Dr Herrmann has received research funding for the University of Pennsylvania from Edwards Lifesciences Inc, Medtronic Inc, and St Jude Medical Inc; is a consultant for and has received research funding from Siemens Medical Inc; and has equity in Microinterventional Devices Inc. Dr Wilensky reports that he is a member of the scientific advisor boards of Cardiostem, GenWay, Soteria, and Vascular Magnetics and has equity interest in Johnson & Johnson. Dr McCormick has received research grants from Abbott Vascular Corp, W. L. Gore, and Boston Scientific Corp. Dr Hirshfeld has served as a member of the FDA Circulatory Systems Device Advisory Panel. No other disclosures are reported.